Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis

European Journal of Internal Medicine

Volumn 25, Issue 3, 2014, Pages 241-246

  Sampaio, Francisco ^a,b   Pimenta, Joana ^b   Bettencourt, Nuno ^a,b   Fontes Carvalho, Ricardo ^a,b   Silva, Ana Paula ^a   Valente, João ^a   Bettencourt, Paulo ^b   Fraga, José ^a   Gama, Vasco ^a  

^a CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Cardiac function; Cirrhosis; Echocardiography; Prognosis

Indexed keywords

ALBUMIN; BILIRUBIN; C REACTIVE PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEPATORENAL SYNDROME; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING; CARDIOMYOPATHY; COMPLICATION; DIASTOLE; LIVER CIRRHOSIS; PATHOPHYSIOLOGY; SYSTOLE;

AGED; CARDIOMYOPATHIES; DIASTOLE; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SYSTOLE;

EID: 84896394367     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.01.011     Document Type: Article

References (30)

1. S.A. Alqahtani, T.R. Fouad, and S.S. Lee Cirrhotic cardiomyopathy Semin Liver Dis 28 2008 59 69
2. S. Moller, and J.H. Henriksen Cardiovascular complications of cirrhosis Gut 57 2008 268 278
3. F. Wong Cirrhotic cardiomyopathy Hepatol Int 3 2009 294 304
4. J.H. Henriksen, J.P. Gøtze, S. Fuglsang, E. Christensen, F. Bendtsen, and S. Møller Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease Gut 52 2003 1511 1517
5. M. Pozzi, S. Carugo, G. Boari, V. Pecci, S. de Ceglia, and S. Maggiolini et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites Hepatology 26 1997 1131 1137
6. K. Kazankov, P. Holland-Fischer, N.H. Andersen, P. Torp, E. Sloth, and N.K. Aagaard et al. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging Liver Int 31 2011 534 540
7. M. Merli, A. Calicchia, A. Ruffa, P. Pellicori, O. Riggio, and M. Giusto et al. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease Eur J Intern Med 24 2013 172 176
8. A. Nazar, M. Guevara, M. Sitges, C. Terra, E. Solà, and C. Guigou et al. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction J Hepatol 58 2013 51 57
9. F. Sampaio, J. Pimenta, N. Bettencourt, R. Fontes-Carvalho, A.P. Silva, and J. Valente et al. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study Liver Int 33 2013 1158 1165
10. M. Cazzaniga, F. Salerno, G. Pagnozzi, E. Dionigi, S. Visentin, and I. Cirello et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt Gut 56 2007 869 875
11. A. Krag, F. Bendtsen, J.H. Henriksen, and S. Møller Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites Gut 59 2010 105 110
12. J. Pimenta, C. Paulo, A. Gomes, S. Silva, F. Rocha-Gonçalves, and P. Bettencourt B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis Liver Int 30 2010 1059 1066
13. L. Ruiz-del-Arbol, A. Monescillo, C. Arocena, P. Valer, P. Ginès, and V. Moreira et al. Circulatory function and hepatorenal syndrome in cirrhosis Hepatology 42 2005 439 447
14. L. Ruiz-del-Arbol, J. Urman, J. Fernández, M. González, M. Navasa, and A. Monescillo et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis Hepatology 38 2003 1210 1218
15. C.M. Yu, J.E. Sanderson, T.H. Marwick, and J.K. Oh Tissue Doppler imaging a new prognosticator for cardiovascular diseases J Am Coll Cardiol 49 2007 1903 1914
16. T. Stanton, R. Leano, and T.H. Marwick Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring Circ Cardiovasc Imaging 2 2009 356 364
17. J. Nahum, A. Bensaid, C. Dussault, L. Macron, D. Clémence, and B. Bouhemad et al. Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients Circ Cardiovasc Imaging. 3 2010 249 256
18. Y.W. Liu, C.T. Su, J.M. Sung, S.P. Wang, Y.R. Su, and C.S. Yang et al. Association of left ventricular longitudinal strain with mortality among stable hemodialysis patients with preserved left ventricular ejection fraction Clin J Am Soc Nephrol 8 2013 1564 1574
19. M. Ersboll, N. Valeur, U.M. Mogensen, M.J. Andersen, J.E. Moller, and E.J. Velazquez et al. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction J Am Coll Cardiol 61 2013 2365 2373
20. S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, and O.A. Smiseth et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 2009 107 133
21. A. Alexopoulou, G. Papatheodoridis, S. Pouriki, C. Chrysohoou, L. Raftopoulos, and C. Stefanadis et al. Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis Transpl Int 25 2012 1174 1181
22. L. Ruiz-Del-Arbol, L. Achecar, R. Serradilla, M.A. Rodriguez-Gandia, M. Rivero, and E. Garrido et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension and a normal creatinine Hepatology 58 2013 1732 1741
23. B.H. Bijnens, M. Cikes, P. Claus, and G.R. Sutherland Velocity and deformation imaging for the assessment of myocardial dysfunction Eur J Echocardiogr 10 2009 216 226
24. V. Mor-Avi, R.M. Lang, L.P. Badano, M. Belohlavek, N.M. Cardim, and G. Derumeaux et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography Eur J Echocardiogr 12 2011 167 205
25. A. Mignot, E. Donal, A. Zaroui, P. Reant, A. Salem, and C. Hamon et al. Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study J Am Soc Echocardiogr 23 2010 1019 1024
26. G.-Y. Cho, T.H. Marwick, H.-S. Kim, M.-K. Kim, K.-S. Hong, and D.-J. Oh Global 2-dimensional strain as a new prognosticator in patients with heart failure J Am Coll Cardiol 54 2009 618 624
27. R. Yildiz, B. Yildirim, M. Karincaoglu, M. Harputluoglu, and F. Hilmioglu Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients J Gastroenterol Hepatol 20 2005 1115 1120
28. P. Bettencourt, A. Azevedo, J. Pimenta, F. Friões, S. Ferreira, and A. Ferreira N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2004 2168 2174
29. V. Cheng, R. Kazanagra, A. Garcia, L. Lenert, P. Krishnaswamy, and N. Gardetto et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391
30. H.N. Kim, and J.L. Januzzi Jr. Natriuretic peptide testing in heart failure Circulation 123 2011 2015 2019